SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammation

Genes and Immunity

Volumn 15, Issue 4, 2014, Pages 233-240

  Maxwell, M J ^a   Srivastava, N ^b   Park, M Y ^b   Tsantikos, E ^a   Engelman, R W ^c   Kerr, W G ^b,d   Hibbs, M L ^a  

^a MONASH UNIVERSITY   (Australia)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d SYRACUSE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DAMAGE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ILEITIS; INFLAMMATORY DISEASE; MOUSE; MYELOPOIESIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SHIP 1 DEFICIENCY; SPLENOMEGALY; ANIMAL; CHRONIC DISEASE; ENZYMOLOGY; GENETICS; ILEUM; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LUNG; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY;

MUS;

INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMALS; CHRONIC DISEASE; ILEUM; INFLAMMATION; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; MYELOPOIESIS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORIC MONOESTER HYDROLASES; PNEUMONIA;

EID: 84902077040     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.9     Document Type: Article

References (45)

1. Fruman DA, Bismuth G. Fine tuning the immune response with PI3K. Immunol Rev 2009; 228: 253-272
2. Hirsch E, Ciraolo E, Ghigo A, Costa C. Taming the PI3K team to hold inflammation and cancer at bay. Pharmacol Ther 2008; 118: 192-205
3. Kerr WG. Inhibitor and activator: Dual functions for SHIP in immunity and cancer. Ann NY Acad Sci 2011; 1217: 1-17
4. Tiwari S, Choi HP, Matsuzawa T, Pypaert M, MacMicking JD. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nat Immunol 2009; 10: 907-917
5. Brooks R, Fuhler GM, Iyer S, Smith MJ, Park MY, Paraiso KH et al. SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J Immunol 2010; 184: 3582-3589
6. Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 1998; 12: 1610-1620. (Pubitemid 28299513
7. Liu Q, Sasaki T, Kozieradzki I, Wakeham A, Itie A, Dumont DJ et al. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 1999; 13: 786-791. (Pubitemid 29169837
8. Ghansah T, Paraiso KH, Highfill S, Desponts C, May S, McIntosh JK et al. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J Immunol 2004; 173: 7324-7330. (Pubitemid 39628170
9. Harder KW, Quilici C, Naik E, Inglese M, Kountouri N, Turner A et al. Perturbed myelo/erythropoiesis in Lyn -deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood 2004; 104: 3901-3910. (Pubitemid 39620136
10. Maxwell MJ, Duan M, Armes JE, Anderson GP, Tarlinton DM, Hibbs ML. Genetic segregation of inflammatory lung disease and autoimmune disease severity in SHIP-1-/- mice. J Immunol 2011; 186: 7164-7175
11. Rauh MJ, Ho V, Pereira C, Sham A, Sly LM, Lam V et al. SHIP represses the generation of alternatively activated macrophages. Immunity 2005; 23: 361-374. (Pubitemid 41443438
12. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166-6173. (Pubitemid 30408793
13. Duan M, Li WC, Vlahos R, Maxwell MJ, Anderson GP, Hibbs ML. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J Immunol 2012; 189: 946-955
14. Kerr WG, Park MY, Maubert M, Engelman RW. SHIP deficiency causes Crohn's disease-like ileitis. Gut 2011; 60: 177-188
15. McLarren KW, Cole AE, Weisser SB, Voglmaier NS, Conlin VS, Jacobson K et al. SHIP-deficient mice develop spontaneous intestinal inflammation and arginasedependent fibrosis. Am J Pathol 2011; 179: 180-188
16. Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 2003; 198: 333-340. (Pubitemid 36987858
17. Collazo MM, Paraiso KH, Park MY, Hazen AL, Kerr WG. Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP. Eur J Immunol 2012; 42: 1785-1795
18. Wang JW, Howson JM, Ghansah T, Desponts C, Ninos JM, May SL et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 2002; 295: 2094-2097. (Pubitemid 34229475
19. Hadidi S, Antignano F, Hughes MR, Wang SK, Snyder K, Sammis GM et al. Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection. Mucosal Immunol 2012; 5: 535-543
20. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-277. (Pubitemid 29523965
21. Nguyen NY, Maxwell MJ, Ooms LM, Davies EM, Hilton AA, Collinge JE et al. An ENU-induced mouse mutant of SHIP1 reveals a critical role of the stem cell isoform for suppression of macrophage activation. Blood 2011; 117: 5362-5371
22. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997; 27: 2366-2374. (Pubitemid 27404323
23. Liu Q, Oliveira-Dos-Santos AJ, Mariathasan S, Bouchard D, Jones J, Sarao R et al. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med 1998; 188: 1333-1342. (Pubitemid 28478021
24. Helgason CD, Kalberer CP, Damen JE, Chappel SM, Pineault N, Krystal G et al. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: Aberrant development and enhanced function of B lymphocytes in SHIP -/- mice. J Exp Med 2000; 191: 781-794
25. Takeshita S, Namba N, Zhao JJ, Jiang Y, Genant HK, Silva MJ et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat Med 2002; 8: 943-949. (Pubitemid 35033697
26. Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA 1998; 95: 11330-11335. (Pubitemid 28450128
27. Maxwell MJ, Yuan Y, Anderson KE, Hibbs ML, Salem HH, Jackson SP. SHIP1 and Lyn kinase negatively regulate integrin aIIbb3 signaling in platelets. J Biol Chem 2004; 279: 32196-32204. (Pubitemid 39014667
28. Wahle JA, Paraiso KH, Costello AL, Goll EL, Sentman CL, Kerr WG. Cutting edge: Dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets. J Immunol 2006; 176: 7165-7169. (Pubitemid 43849017
29. Oh SY, Zheng T, Bailey ML, Barber DL, Schroeder JT, Kim YK et al. Src homology 2 domain-containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung. J Allergy Clin Immunol 2007; 119: 123-131. (Pubitemid 46037797
30. Baran CP, Tridandapani S, Helgason CD, Humphries RK, Krystal G, Marsh CB. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. J Biol Chem 2003; 278: 38628-38636. (Pubitemid 37221760
31. Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 2004; 21: 227-239. (Pubitemid 39094052
32. Kuroda E, Ho V, Ruschmann J, Antignano F, Hamilton M, Rauh MJ et al. SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils. J Immunol 2009; 183: 3652-3660
33. Smith SM, Lee DK, Lacy J, Coleman DL. Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor. Am J Respir Cell Mol Biol 1990; 2: 59-68
34. Bilyk N, Holt PG. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J Exp Med 1993; 177: 1773-1777. (Pubitemid 23146144
35. Hawley RG, Fong AZ, Burns BF, Hawley TS. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 1992; 176: 1149-1163
36. Maeda K, Baba Y, Nagai Y, Miyazaki K, Malykhin A, Nakamura K et al. IL-6 blocks a discrete early step in lymphopoiesis. Blood 2005; 106: 879-885. (Pubitemid 41076427
37. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987; 84: 9035-9039. (Pubitemid 18055335
38. Tsuji K, Lyman SD, Sudo T, Clark SC, Ogawa M. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 1992; 79: 2855-2860
39. Nakamura K, Kouro T, Kincade PW, Malykhin A, Maeda K, Coggeshall KM. Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow. J Exp Med 2004; 199: 243-254. (Pubitemid 38129704
40. Hazen AL, Smith MJ, Desponts C, Winter O, Moser K, Kerr WG. SHIP is required for a functional hematopoietic stem cell niche. Blood 2009; 113: 2924-2933
41. Hoggatt J, Pelus LM. Many mechanisms mediating mobilization: An alliterative review. Curr Opin Hematol 2011; 18: 231-238
42. Desponts C, Hazen AL, Paraiso KH, Kerr WG. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood 2006; 107: 4338-4345. (Pubitemid 43801359
43. Tu Z, Ninos JM, Ma Z, Wang JW, Lemos MP, Desponts C et al. Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein. Blood 2001; 98: 2028-2038
44. Tarasenko T, Kole HK, Chi AW, Mentink-Kane MM, Wynn TA, Bolland S. Tcell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc Natl Acad Sci USA 2007; 104: 11382-11387. (Pubitemid 47175149
45. Anderson BE, McNiff JM, Matte C, Athanasiadis I, Shlomchik WD, Shlomchik MJ.Recipient CD4θ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 2004; 104: 1565-1573.